Related Experiment Video
Updated: Apr 19, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
7SK small nuclear RNA inhibits cancer cell proliferation through apoptosis induction
Farid Keramati1, Ehsan Seyedjafari, Parviz Fallah
1Department of Biotechnology, College of Science, University of Tehran, Tehran, Iran.
Abstract:
7SK small nuclear RNA (snRNA) is a 331-333-bp non-coding RNA, which recruits HEXIM 1/2 protein to inhibit positive elongation factor b (P-TEFb) activity. P-TEFb is an essential factor in alleviating promoter-proximal paused RNA polymerase II (Pol II) and initiating the productive elongation phase of gene transcription. Without this protein, Pol II will remain in its hypophosphorylated state, and no transcription occurs. In this study, we inhibited P-TEFb activity by over-expressing 7SK snRNA in human embryonic kidney (HEK) 293T cancer cell line. This inhibition led to a significant decrease in cell viability, which can be due to the transcription inhibition. Moreover, 7SK snRNA over-expression promoted apoptosis in cancerous cells. Our results suggest 7SK snRNA as a potential endogenous anti-cancer agent, and to the best of our knowledge, this is the first study that uses a long non-coding RNA's over-expression against cancer cell growth and proliferation.
Insights
Over-expressing 7SK small nuclear RNA (snRNA) inhibits transcription by blocking P-TEFb. This approach reduced cancer cell viability and promoted apoptosis, suggesting 7SK snRNA as a potential anti-cancer agent.
Area of Science:
- Molecular Biology
- Cancer Research
- Gene Regulation
Background:
- 7SK small nuclear RNA (snRNA) is a non-coding RNA that regulates transcription by inhibiting positive elongation factor b (P-TEFb).
- P-TEFb is crucial for RNA polymerase II (Pol II) transcription, and its inhibition halts gene expression.
- Uncontrolled transcription is a hallmark of cancer, making transcription factors like P-TEFb potential therapeutic targets.
Purpose of the Study:
- To investigate the anti-cancer potential of over-expressing 7SK snRNA.
- To determine the effect of 7SK snRNA over-expression on cancer cell viability and apoptosis.
- To explore the mechanism of 7SK snRNA-mediated inhibition of P-TEFb in cancer cells.
Main Methods:
- Over-expression of 7SK snRNA in human embryonic kidney (HEK) 293T cancer cells.
- Assessment of cell viability using standard assays.
- Induction of apoptosis was measured in response to 7SK snRNA over-expression.
Main Results:
- Over-expression of 7SK snRNA led to significant inhibition of P-TEFb activity.
- A notable decrease in cancer cell viability was observed.
- 7SK snRNA over-expression induced apoptosis in the treated cancer cells.
Conclusions:
- 7SK snRNA over-expression effectively inhibits cancer cell proliferation and survival.
- This study identifies 7SK snRNA as a potential endogenous anti-cancer therapeutic agent.
- This research pioneers the use of long non-coding RNA over-expression for cancer treatment.
Related Concept Videos
Experimental RNAi
MicroRNAs
MicroRNAs
The Intrinsic Apoptotic Pathway
Negative Regulator Molecules
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...

